Completed
Diagnosis and Treatment of Patients With Heart and Vascular Disease (Training Protocol)
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2021-03-12
7829
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
An important mission of the National Institutes of Health (NIH) is to develop and carry out research studies designed to improve understanding of disease processes and treatments. Clinical research continues to become more focused on specific diseases and the signs and symptoms of diseases in specific groups of people and patients. This study is designed to permit inpatient evaluation and care of patients with heart disease who do not qualify to participate in research studies being conducted by the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). These patients are valuable to the Cardiology Branch of the NHLBI because they help to improve training and experience of its researchers.
CONDITIONS
Official Title
Evaluation of Patients With Heart Disease Not Eligible for Research Protocols
Who Can Participate
Eligibility Criteria
You may qualify if you...
- INCLUSION CRITERIA:
Patients with signs or symptoms or risk of cardiovascular disease may participate in this training protocol. The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol:
Coronary artery disease with effort or rest angina or inducible myocardial ischemia as determined by noninvasive testing.
Valvular heart disease.
Cardiomyopathies, including restrictive, congestive, and hypertrophic phenotypes.
Peripheral-artery disease of upper or lower extremities, with intermittent pain with activity (e.g. claudication) or limb-threatening ischemia.
Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy.
Congenital heart disease, with communications between chambers or major vessels
Heart surgery patients treated at the Clinical Center prior to closure of the Heart Surgery Branch in 1990
EXCLUSION CRITERIA:
Pregnancy, for those patients who require testing or treatment requiring dobutamine, gadolinium or contrast media or radiation exposure.
Inability of patient, parent or legal guardian to provide informed consent.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Status Unknown
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here